Arrowhead Pharmaceuticals (ARWR) EBT Growth (1y) (2011 - 2026)
Arrowhead Pharmaceuticals (ARWR) EBT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.10% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,140.26% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 71.54% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.15% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 88.57% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Arrowhead Pharmaceuticals | 11.98 Bn | 10.18 Bn | - | -137.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -137.22% |
| Dec 31, 2025 | 116.14% |
| Sep 30, 2025 | 120.90% |
| Jun 30, 2025 | -2.94% |
| Mar 31, 2025 | 391.05% |
| Dec 31, 2024 | -26.26% |
| Sep 30, 2024 | -58.54% |
| Jun 30, 2024 | -68.28% |
| Mar 31, 2024 | -366.37% |
| Dec 31, 2023 | -231.84% |
| Sep 30, 2023 | -32.66% |
| Jun 30, 2023 | -43.50% |
| Mar 31, 2023 | 7.46% |
| Dec 31, 2022 | 33.53% |
| Sep 30, 2022 | -29.64% |
| Jun 30, 2022 | -140.76% |
| Mar 31, 2022 | 265.43% |
| Dec 31, 2021 | -203.26% |
| Sep 30, 2021 | -30.85% |
| Jun 30, 2021 | -119.85% |